UROGEN PHARMA LTD's ticker is and the CUSIP is M96088905. A total of 3 filers reported holding UROGEN PHARMA LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144,303 | +144.6% | 10,300 | +80.7% | 0.00% | – |
| Q2 2023 | $58,995 | +236.0% | 5,700 | +200.0% | 0.00% | – |
| Q1 2023 | $17,556 | +295.9% | 1,900 | +280.0% | 0.00% | – |
| Q4 2022 | $4,435 | -91.1% | 500 | -16.7% | 0.00% | – |
| Q3 2022 | $50,000 | -94.1% | 600 | -98.8% | 0.00% | -100.0% |
| Q3 2021 | $841,000 | +10.1% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $764,000 | -53.8% | 50,000 | -41.1% | 0.00% | -50.0% |
| Q1 2021 | $1,654,000 | -19.2% | 84,900 | -25.3% | 0.00% | -50.0% |
| Q4 2020 | $2,047,000 | -25.3% | 113,600 | -20.1% | 0.00% | -55.6% |
| Q3 2020 | $2,741,000 | -25.2% | 142,100 | +1.4% | 0.01% | -47.1% |
| Q2 2020 | $3,662,000 | +609.7% | 140,200 | +385.1% | 0.02% | +325.0% |
| Q1 2020 | $516,000 | -5.7% | 28,900 | +76.2% | 0.00% | 0.0% |
| Q4 2019 | $547,000 | +13575.0% | 16,400 | +16300.0% | 0.00% | – |
| Q4 2018 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 10,300 | $144,303 | 0.00% |
| JANE STREET GROUP, LLC | 14,100 | $197,541 | 0.00% |
| SIMPLEX TRADING, LLC | 8,500 | $119 | 0.00% |